Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chad A, Stoltz"'
Autor:
Mazin I. Foteh, Stefanos Giannopoulos, Peter A. Soukas, Giuseppe Vadalà, Brian A Kuhn, Francesco Speziale, Ehrin J. Armstrong, Chad L Stoltz, Carlos Mena-Hurtado
Publikováno v:
Journal of Endovascular Therapy. 28:93-99
Purpose: To report the use of intravascular lithotripsy (IVL) in the treatment of calcified carotid artery lesions. Materials and Methods: The records of 21 high-surgical-risk patients (mean age 75.1±8.1 years; 17 men) who were treated at 8 centers
Autor:
Xin, Tang, Jeffery B, DeLisio, Sufian, Alnemrat, Zachary, Hicks, Lauren, Stevens, Chad A, Stoltz, Joseph P, Hooper, Bryan W, Eichhorn, Michael R, Zachariah, Kit H, Bowen, Dennis H, Mayo
Publikováno v:
Inorganic chemistry. 57(14)
The combustion mechanism of [AlCp*]
Autor:
Jared C. Gump, Chad A. Stoltz, Benjamin G. Freedman, Suhithi M. Peiris, Mark Elert, Michael D. Furnish, William W. Anderson, William G. Proud, William T. Butler
Publikováno v:
AIP Conference Proceedings.
2,6‐diamino‐3,5‐dinitropyrazine‐1‐oxide (LLM‐105) is an energetic ingredient that has an impact sensitivity close to that of TATB, yet a calculated energy content close to HMX. Reported tests of formulated LLM‐105 reveal that it is a go
Autor:
Jared C. Gump, Chad A. Stoltz, Suhithi M. Peiris, Mark Elert, Michael D. Furnish, Ricky Chau, Neil Holmes, Jeffrey Nguyen
Publikováno v:
AIP Conference Proceedings.
Hexanitrohexaazaisowurtzitane (CL‐20) is one of the few ingredients developed since World War II to be considered for transition to military use. Five polymorphs have been identified for CL‐20 by FTIR measurements (α, β, γ, e, ζ). As CL‐20
Publikováno v:
CrystEngComm; Feb2011, Vol. 13 Issue 4, p1074-1076, 3p